FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like 5 Biotechs Releasing Highly-Anticipated Data at ASCO May 18, 2017 Mark Your Calendars: 4 Biotechs Facing FDA Decision Dates in May April 26, 2017 Pharma Scores Big Win: to Ink FDA User Fee Bill, Saving 5,000 Jobs August 3, 2017
